Surgically Clean Air was launched in 2010 by Marshal Sterio and Douglas Eaton to address the critical need to improve indoor air quality within commercial applications. The company’s first-generation air treatment system was invented as a rapid response to the SARS epidemic. Building on their early success, Surgically Clean Air leveraged their in-house research and development expertise to expand their product line across multiple industries. The company is based in Toronto, Canada, with offices throughout the United States and one location in the United Kingdom.
Over the course of the COVID-19 pandemic, the Greater Toronto Airports Authority (GTAA) has focused on equipping its facilities with technology to keep travelers and staff safe...
